ICON Public (NASDAQ:ICLR – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $14.65-$15.15 for the period, compared to the consensus earnings per share estimate of $14.94. The company issued revenue guidance of $8.48-$8.72 billion, compared to the consensus revenue estimate of $8.64 billion.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on ICLR shares. Mizuho restated a buy rating and issued a $346.00 target price on shares of ICON Public in a report on Thursday, April 4th. Barclays boosted their price objective on shares of ICON Public from $325.00 to $355.00 and gave the stock an overweight rating in a research note on Friday, February 23rd. Evercore ISI decreased their price objective on shares of ICON Public from $350.00 to $330.00 and set an outperform rating for the company in a research note on Friday. Truist Financial boosted their price objective on shares of ICON Public from $357.00 to $367.00 and gave the stock a buy rating in a research note on Friday, February 23rd. Finally, Robert W. Baird boosted their price objective on shares of ICON Public from $362.00 to $363.00 and gave the stock an outperform rating in a research note on Friday. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and an average price target of $321.64.
Read Our Latest Stock Report on ICON Public
ICON Public Stock Performance
ICON Public (NASDAQ:ICLR – Get Free Report) last released its quarterly earnings results on Wednesday, February 21st. The medical research company reported $3.40 EPS for the quarter, topping the consensus estimate of $3.27 by $0.13. The business had revenue of $2.07 billion during the quarter, compared to analyst estimates of $2.08 billion. ICON Public had a net margin of 8.30% and a return on equity of 11.84%. As a group, equities analysts anticipate that ICON Public will post 14.4 EPS for the current fiscal year.
About ICON Public
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
See Also
- Five stocks we like better than ICON Public
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks Leading the U.S. Agriculture Comeback
- What Investors Need to Know to Beat the Market
- How to Use Put Debit Spreads to Profit From Falling Stocks
- What does consumer price index measure?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.